Inventor
Yuka Sasaki
Inventor
Machida, JP
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07KPeptides35%
A61KPreparations for medical, dental or toiletry purposes24%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
PatentTitleYear
8,491,902'Medicament comprising recombinant antibody against chemokine receptor CCR4'20138,481,039'Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor'20138,173,781'Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor'20128,163,282'Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor'20128,093,361'Anti-perp antibody'20127,851,601'Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2013Patents assigned to KYOWA HAKKO KIRIN CO LTD (6)· patent assignee history
2010–2013Based in Machida, JP· patent location history
2012–2013Patents assigned to SASAKI YUKA (5)· patent assignee history
2012–2013Patents assigned to SHITARA KENYA (5)· patent assignee history
2012–2013Patents assigned to FURUYA AKIKO (4)· patent assignee history
2012–2013Patents assigned to ANDO HIROSHI (3)· patent assignee history
2012–2013Based in Tokyo, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| KYOWA HAKKO KIRIN CO LTD | 6 | 2010–2013 |
| SASAKI YUKAself | 5 | 2012–2013 |
| SHITARA KENYA | 5 | 2012–2013 |
| FURUYA AKIKO | 4 | 2012–2013 |
| ANDO HIROSHI | 3 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Machida, JP | 3 | 2010–2013 |
| Tokyo, JP | 3 | 2012–2013 |